J&J's Remicade losing ground in Quebec health plan despite court victory

Johnson & Johnson's Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec's public drug program, even after a court ruling reinstated full coverage in January, a Reuters analysis of government data shows.

from Reuters: Health News https://ift.tt/2Q9Vhh3